About: Public Readiness and Emergency Preparedness Act

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Public Readiness and Emergency Preparedness Act Goto Sponge NotDistinct Permalink

An Entity of Type : dbo:FootballMatch, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FPublic_Readiness_and_Emergency_Preparedness_Act

The Public Readiness and Emergency Preparedness Act (PREPA), passed by the United States Congress and signed into law by President of the United States George W. Bush in December 2005 (as part of Pub.L. 109–148 (text) (PDF)), is a controversial tort liability shield intended to protect vaccine manufacturers from financial risk in the event of a declared public health emergency. The part of PREPA that actually affords such protection is now codified at 42 U.S.C. § 247d-6d. The act specifically affords to drug makers immunity from actions related to the manufacture, testing, development, distribution, administration and use of medical countermeasures against chemical, biological, radiological and nuclear agents of terrorism, epidemics, and pandemics. PREPA strengthens and consolidates the ov

Attributes	Values
rdf:type	football match
rdfs:label	Public Readiness and Emergency Preparedness Act (en)
rdfs:comment	The Public Readiness and Emergency Preparedness Act (PREPA), passed by the United States Congress and signed into law by President of the United States George W. Bush in December 2005 (as part of Pub.L. 109–148 (text) (PDF)), is a controversial tort liability shield intended to protect vaccine manufacturers from financial risk in the event of a declared public health emergency. The part of PREPA that actually affords such protection is now codified at 42 U.S.C. § 247d-6d. The act specifically affords to drug makers immunity from actions related to the manufacture, testing, development, distribution, administration and use of medical countermeasures against chemical, biological, radiological and nuclear agents of terrorism, epidemics, and pandemics. PREPA strengthens and consolidates the ov (en)
dcterms:subject	Acts of the 109th United States Congress United States federal health legislation Disaster preparedness in the United States Vaccination in the United States Drug policy of the United States Vaccination law
Wikipage page ID	4136457 (xsd:integer)
Wikipage revision ID	1101851985 (xsd:integer)
Link from a Wikipage to another Wikipage	President of the United States Epidemic Gannett News Service Bill Frist Dennis Hastert Appropriations bill (United States) Pharmaceutical United States Congress United States Constitution United States District Court for the District of Columbia United States House of Representatives United States Secretary of Health and Human Services University of Pittsburgh Vaccine Derivative suit Nursing home care in the United States George W. Bush Conference report Thimerosal Lobbying Complaint COVID-19 pandemic in the United States Acts of the 109th United States Congress Tort Health and Human Services Vaccines for the New Millennium Act United States federal health legislation Eagle Forum dbr:Ethylmercury Federal Food, Drug, and Cosmetic Act Food and Drug Administration Pandemic Disease Disaster preparedness in the United States Vaccination in the United States Guillain–Barré syndrome Ted Kennedy Public Citizen Drug policy of the United States Bioterrorism Vaccination law George W. Bush Administration Influenza Nathan Deal Public health Salt Lake City Weekly Vaccine injury Santa Monica Mirror United States Senator U.S. Department of Defense Jurist Legal News & Research dbr:A-CHAMP
Link from a Wikipage to an external page	http://www.gallatinnewsexaminer.com/apps/pbcs.dll/article%3FAID=/20060209/NEWS02/602090405/1309/MTCN04 http://clerk.house.gov/evs/2005/roll669.xml https://www.senate.gov/legislative/LIS/roll_call_lists/roll_call_vote_cfm.cfm%3Fcongress=109&session=1&vote=00366 http://www.cidrap.umn.edu/cidrap/content/influenza/biz-plan/news/dec2805liability.html http://www.smmirror.com/MainPages/DisplayArticleDetails.asp%3Feid=2871 https://web.archive.org/web/20060301044622/http:/www.harkin.senate.gov/news.cfm%3Fid=251591 https://web.archive.org/web/20060629171751/http:/www.slweekly.com/editorial/2006/cityweek_1_2006-02-09.cfm https://www.govinfo.gov/content/pkg/USCODE-2019-title42/pdf/USCODE-2019-title42-chap12-front.pdf http://jurist.law.pitt.edu/paperchase/2006/02/vaccine-liability-law-changes-proposed.php
sameAs	Public Readiness and Emergency Preparedness Act Public Readiness and Emergency Preparedness Act Public Readiness and Emergency Preparedness Act
dbp:wikiPageUsesTemplate	dbt:No_footnotes dbt:Reflist dbt:Short_description dbt:Usc dbt:Uspl dbt:Usstat dbt:Wikisource dbt:Infobox_U.S._legislation dbt:Vaccines
cite public law	109 (xsd:integer)
effective date	December 2005 (en)
public law url	https://www.govinfo.gov/content/pkg/USCODE-2019-title42/pdf/USCODE-2019-title42-chap12-front.pdf
shorttitle	Public Readiness and Emergency Preparedness Act (en)
enacted by	109 (xsd:integer)
nickname	PREPA (en)
has abstract	The Public Readiness and Emergency Preparedness Act (PREPA), passed by the United States Congress and signed into law by President of the United States George W. Bush in December 2005 (as part of Pub.L. 109–148 (text) (PDF)), is a controversial tort liability shield intended to protect vaccine manufacturers from financial risk in the event of a declared public health emergency. The part of PREPA that actually affords such protection is now codified at 42 U.S.C. § 247d-6d. The act specifically affords to drug makers immunity from actions related to the manufacture, testing, development, distribution, administration and use of medical countermeasures against chemical, biological, radiological and nuclear agents of terrorism, epidemics, and pandemics. PREPA strengthens and consolidates the oversight of litigation against pharmaceutical companies under the purview of the secretary of Health and Human Services (HHS). PREPA provides $3.8 billion for pandemic influenza preparedness to protect public health in the case of a pandemic disease outbreak. Vaccine manufacturers lobbied for the legislation, which would effectively preempt state vaccine safety laws in the case of an emergency declaration by HHS, by making clear they would not produce new vaccines unless the legislation was enacted. Wikisource has original text related to this article:Public Readiness and Emergency Preparedness Act During and in the aftermath of the 2020–21 COVID-19 pandemic in the United States, PREPA is being invoked in a variety of lawsuits, many involving skilled nursing or assisted living facilities where COVID-19 countermeasures including the administration or non-administration of vaccines is said to have resulted in or contributed to resident deaths. Although PREPA was around for more than 15 years, prior to COVID-19, the act's defensive application in litigation was not widespread, but now the application of the act is being included more frequently in a variety of COVID-19 related lawsuits, including Shareholder Derivative Litigation. (en)
colloquialacronym	PREPA (en)
longtitle	Public Readiness and Emergency Preparedness Act (en)
gold:hypernym	Shield
prov:wasDerivedFrom	wikipedia-en:Public_Readiness_and_Emergency_Preparedness_Act?oldid=1101851985&ns=0
page length (characters) of wiki page	13916 (xsd:nonNegativeInteger)
foaf:isPrimaryTopicOf	wikipedia-en:Public_Readiness_and_Emergency_Preparedness_Act
is Link from a Wikipage to another Wikipage of	Public health emergency (United States) Deployment of COVID-19 vaccines PREPA

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 60 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software